4:53 PM
 | 
Jul 22, 2013
 |  BC Extra  |  Politics & Policy

HHS excluding Orphans from 340B

HHS issued a final rule that excludes Orphan drugs used for an FDA-approved Orphan indication from discounting under Medicare's 340B program. The 340B program requires manufacturers to...

Read the full 119 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >